Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayan Mukherjee

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Science (New York, N.Y.)|December 16, 2014
Core and region-enriched networks of behaviorally regulated genes and the singing genomeOsceola Whitney, Andreas R Pfenning, Jason T Howard, et al.
Plos One|April 3, 2008
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancerKelly H Salter, Chaitanya R Acharya, Kelli S Walters, et al.
Elife|May 9, 2023
Universal gut microbial relationships in the gut microbiome of wild baboonsKimberly E Roche, Johannes R Bjork, Mauna R Dasari, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
The Lancet. Oncology|February 1, 2011
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialHervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
The Lancet. Oncology|November 21, 2007
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialHervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
JAMA|January 10, 2012
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587Chaitanya R Acharya, David S Hsu, Carey K Anders, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Science (New York, N.Y.)|December 16, 2014
Core and region-enriched networks of behaviorally regulated genes and the singing genomeOsceola Whitney, Andreas R Pfenning, Jason T Howard, et al.
Plos One|April 3, 2008
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancerKelly H Salter, Chaitanya R Acharya, Kelli S Walters, et al.
Elife|May 9, 2023
Universal gut microbial relationships in the gut microbiome of wild baboonsKimberly E Roche, Johannes R Bjork, Mauna R Dasari, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.
The Lancet. Oncology|February 1, 2011
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialHervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
The Lancet. Oncology|November 21, 2007
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialHervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
JAMA|January 10, 2012
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587Chaitanya R Acharya, David S Hsu, Carey K Anders, et al.
Pageof 13